Monthly Injection Reduces Body Weight by 16% in Landmark Obesity Study
A new drug developed by California-based pharmaceutical company Amgen has shown strong potential as an effective obesity treatment. In a completed phase II trial, participants receiving a once-monthly injection of the drug—called MariTide—lost up to 16% of their body weight within a year. That level of weight loss is similar to the average results seen […]
Monthly Injection Reduces Body Weight by 16% in Landmark Obesity Study Read More »









